Death induced by survival gene elimination (DISE) contributes to neurotoxicity in Alzheimer's disease
暂无分享,去创建一个
C. Geula | D. Green | M. Peter | E. Rogalski | Adriana B Ferreira | R. Vassar | J. Kessler | E. Bartom | Bradlee L. Heckmann | A. E. Murmann | Joseph R. Mazzulli | J. Mazzulli | Kristina Fredriksen | K. Sadleir | Bidur Paudel | Si-Yeon Jeong | Carolina Pena Martinez | Alexis D. Rickman | Ashley Haluck-Kangas | Amira Affaneh | C. Martinez | Adriana Ferreira | Alexis Rickman | Katherine R. Sadleir
[1] M. Peter,et al. The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference , 2022, Cell Death & Disease.
[2] Keun-A Chang,et al. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease , 2022, International journal of biological sciences.
[3] Xue Bai,et al. MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders , 2022, Frontiers in Molecular Neuroscience.
[4] F. Schmitt,et al. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology. , 2022, Brain : a journal of neurology.
[5] M. Peter,et al. Identification of the toxic 6mer seed consensus in human cancer cells , 2020, bioRxiv.
[6] M. Hafner,et al. CD95/Fas ligand mRNA is toxic to cells , 2018, bioRxiv.
[7] M. Peter,et al. DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases , 2021, Journal of experimental & clinical cancer research : CR.
[8] B. Tang,et al. p38 MAPK‐mediated loss of nuclear RNase III enzyme Drosha underlies amyloid beta‐induced neuronal stress in Alzheimer's disease , 2021, Aging cell.
[9] M. Peter,et al. SPOROS: A pipeline to analyze DISE/6mer seed toxicity , 2021, bioRxiv.
[10] D. Matei,et al. The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer , 2021, Cancer Research.
[11] M. Taheri,et al. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease , 2021, Frontiers in Aging Neuroscience.
[12] K. Xia,et al. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy , 2021, Theranostics.
[13] Inhan Lee,et al. tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms. , 2020, Journal of Alzheimer's disease : JAD.
[14] F. Uchiumi,et al. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model. , 2020, Biological & pharmaceutical bulletin.
[15] M. Peter,et al. 6mer Seed Toxicity in Viral microRNAs , 2019, bioRxiv.
[16] D. Green,et al. LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease , 2019, Cell.
[17] J. Kessler,et al. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease , 2019, Annals of neurology.
[18] J. Power,et al. Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together , 2019, Front. Neurosci..
[19] P. Palumaa,et al. Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells. , 2019, Journal of Alzheimer's disease : JAD.
[20] F. Gage,et al. Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. , 2018, Annual review of genetics.
[21] M. Hafner,et al. 6mer seed toxicity in tumor suppressive microRNAs , 2018, Nature Communications.
[22] Benedikt Zott,et al. What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.
[23] J. Satoh,et al. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models , 2018, PloS one.
[24] Jing-Min Lu,et al. MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] Michael W. Lutz,et al. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework , 2018, Alzheimer's & Dementia.
[26] James C. Cummings,et al. Profiling of m6A RNA modifications identified an age‐associated regulation of AGO2 mRNA stability , 2018, Aging cell.
[27] M. Peter,et al. Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells , 2018, bioRxiv.
[28] M. Peter,et al. DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells. , 2018, Trends in cancer.
[29] P. Palumaa,et al. In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells , 2017, PloS one.
[30] D. Scholtens,et al. Temporo-cerebellar connectivity underlies timing constraints in audition , 2017, eLife.
[31] M. Peter,et al. Induction of DISE in ovarian cancer cells in vivo , 2017, bioRxiv.
[32] H. Erfle,et al. Dicer and microRNAs protect adult dopamine neurons , 2017, Cell Death and Disease.
[33] T. Dawson,et al. Mitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics. , 2017, Annual review of pharmacology and toxicology.
[34] H. Mizuguchi,et al. Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA , 2016, Molecular therapy. Nucleic acids.
[35] Sashwati Roy. miRNA in Macrophage Development and Function. , 2016, Antioxidants & redox signaling.
[36] V. Kim,et al. Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis , 2016, Proceedings of the National Academy of Sciences.
[37] D. Krainc,et al. α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models , 2016, Proceedings of the National Academy of Sciences.
[38] Y. Tong,et al. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[39] S. Hammond,et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS‐causing mutations: a new mechanism for ALS , 2015, The EMBO journal.
[40] T. Tuschl,et al. Biochemical isolation of Argonaute protein complexes by Ago-APP , 2015, Proceedings of the National Academy of Sciences.
[41] Manzoor Ahmad Sofi,et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[42] D. Green,et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins , 2015, Nature Cell Biology.
[43] Burkhard Becher,et al. Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.
[44] N. Seyfried,et al. Stress induces p38 MAPK-mediated phosphorylation and inhibition of Drosha-dependent cell survival. , 2015, Molecular cell.
[45] Martin Prince,et al. World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors , 2014 .
[46] A. Lang,et al. Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice , 2014, Neuroscience.
[47] M. Peter,et al. Death induced by CD95 or CD95 ligand elimination. , 2014, Cell reports.
[48] B. Cullen,et al. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential , 2014, Nucleic acids research.
[49] Mark T. W. Ebbert,et al. Genetics of Alzheimer's Disease , 2013, BioMed research international.
[50] Carlo Caltagirone,et al. Inverse occurrence of cancer and Alzheimer disease , 2013, Neurology.
[51] T. Südhof,et al. Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.
[52] D. Tollervey,et al. Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.
[53] D. Sosnowska,et al. Aging‐induced dysregulation of Dicer1‐dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.
[54] S. Pradervand,et al. Comprehensive Expression Analyses of Neural Cell-Type-Specific miRNAs Identify New Determinants of the Specification and Maintenance of Neuronal Phenotypes , 2013, The Journal of Neuroscience.
[55] Sandra Weintraub,et al. Youthful Memory Capacity in Old Brains: Anatomic and Genetic Clues from the Northwestern SuperAging Project , 2013, Journal of Cognitive Neuroscience.
[56] Thomas Tuschl,et al. Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing. , 2012, Methods.
[57] C. Kahn,et al. Role of microRNA processing in adipose tissue in stress defense and longevity. , 2012, Cell metabolism.
[58] F. Slack,et al. Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain , 2012, PloS one.
[59] I. MacRae,et al. The Crystal Structure of Human Argonaute2 , 2012, Science.
[60] Natalie G Ahn,et al. Quantitative functions of Argonaute proteins in mammalian development. , 2012, Genes & development.
[61] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[62] S. Diamond,et al. Small Molecule Inhibition of RISC Loading , 2011, ACS chemical biology.
[63] F. Marabita,et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b , 2011, Nature Immunology.
[64] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[65] George A Calin,et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing , 2011, Proceedings of the National Academy of Sciences.
[66] L. Jungbauer,et al. Preparing synthetic Aβ in different aggregation states. , 2011, Methods in molecular biology.
[67] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[68] E. Bigio,et al. Calpain-Mediated Tau Cleavage: A Mechanism Leading to Neurodegeneration Shared by Multiple Tauopathies , 2011, Molecular medicine.
[69] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[70] M. Valko,et al. Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.
[71] C. D. Fowler,et al. Argonaute 2 in dopamine 2 receptor–expressing neurons regulates cocaine addiction , 2010, The Journal of experimental medicine.
[72] O. Arancio,et al. Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. , 2010, Journal of visualized experiments : JoVE.
[73] C. Tabin,et al. miRNA malfunction causes spinal motor neuron disease , 2010, Proceedings of the National Academy of Sciences.
[74] Walter J. Lukiw,et al. Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.
[75] T. Tomasi,et al. Dicer is regulated by cellular stresses and interferons. , 2009, Molecular immunology.
[76] M. Zavolan,et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. , 2008, RNA.
[77] T. Tuschl,et al. Structure of the guide-strand-containing argonaute silencing complex , 2008, Nature.
[78] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[79] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[80] Qihong Huang,et al. MicroRNAs can regulate human APP levels , 2008, Molecular Neurodegeneration.
[81] Z. Paroo,et al. A small molecule enhances RNA interference and promotes microRNA processing , 2008, Nature Biotechnology.
[82] Michael T. McManus,et al. Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus , 2008, The Journal of Neuroscience.
[83] E. Izaurralde,et al. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay , 2008, Nature Structural &Molecular Biology.
[84] P. Greengard,et al. Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.
[85] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[86] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[87] K. Kosik. The neuronal microRNA system , 2006, Nature Reviews Neuroscience.
[88] N. Bonini,et al. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. , 2006, Molecular cell.
[89] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[90] Evan Z. Macosko,et al. Functional and Selective RNA Interference in Developing Axons and Growth Cones , 2006, The Journal of Neuroscience.
[91] Hirohisa Tajima,et al. Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. , 2006, Current neuropharmacology.
[92] Stefan L Ameres,et al. Cleavage of the siRNA passenger strand during RISC assembly in human cells , 2006, EMBO reports.
[93] R. Russell,et al. Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR Evolution , 2005, Cell.
[94] Qinghua Liu,et al. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. , 2005, Genes & development.
[95] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[96] V. Kim,et al. The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.
[97] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[98] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[99] B. Cullen,et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.
[100] E. Lai. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.
[101] M. Vitek,et al. Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[102] A. Pasquinelli,et al. A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.
[103] D. Butterfield,et al. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35). , 2001, Journal of the American Chemical Society.
[104] A. Caudy,et al. Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .
[105] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[106] R. Nitsch,et al. The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress , 2000, The Journal of Neuroscience.
[107] Yuhui Liu,et al. Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells , 2000, Journal of neurochemistry.
[108] S. H. Kim,et al. Function and dysfunction of the presenilins. , 1999, American journal of human genetics.
[109] S. Younkin. The role of A beta 42 in Alzheimer's disease. , 1998, Journal of physiology, Paris.
[110] J. de Maeyer-Guignard,et al. Type I interferons. , 1998, International reviews of immunology.
[111] T. Holzman,et al. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. , 1994, Journal of neuroscience research.
[112] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[113] D. Kaplan,et al. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.
[114] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[115] A. Ferreira,et al. Ganglioside-enhanced neurite growth: evidence for a selective induction of high-molecular-weight MAP-2 , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[116] B. Peddie,et al. Enoxacin for the treatment of urinary tract infection. , 1985, The New Zealand medical journal.
[117] P. Gray,et al. Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation. , 1977, Nucleic acids research.